Works by Putri, Herwandhani

Results: 16

In Vitro Study of the Combination of Doxorubicin, Curcuma xanthorrhiza, Brucea javanica, and Ficus séptica as a Potential Novel Therapy for Metastatic Breast Cancer.

Published in:

Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2019, v. 30, n. 1, p. 15, doi. 10.14499/indonesianjpharm30iss1pp15

By:

Ika Rahmawati Sutejo;
Herwandhani Putri;
Sri Handayani;
Riris Istighfari Jenie;
Edy Meiyanto

Publication type:

Article

SYNTHESIS AND CYTOTOXIC ACTIVITY OF 2,5-BIS(4-BORONIC ACID)BENZYLIDINE CYCLOPENTANONE ON HER2 OVEREXPRESSED-CANCER CELLS.

Published in:

Indonesian Journal of Pharmacy / Majalah Farmasi Indonesia, 2017, v. 28, n. 2, p. 74, doi. 10.14499/indonesianjpharm28iss2pp74

By:

Utomo, Rohmad Yudi;
Putri, Herwandhani;
Pudjono;
Susidarti, Ratna Asmah;
Jenie, Riris Istighfari;
Meiyanto, Edy

Publication type:

Article

Bioinformatics Analysis of the Genetic and Epigenetic Alterations of Bone Morphogenetic Protein Receptors in Metastatic Breast Cancer.

Published in:

Biochemical Genetics, 2024, v. 62, n. 2, p. 594, doi. 10.1007/s10528-023-10445-2

By:

Hermawan, Adam;
Putri, Herwandhani

Publication type:

Article

Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy.

Published in:

BMC Genomic Data, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12863-022-01086-2

By:

Hermawan, Adam;
Putri, Herwandhani

Publication type:

Article

Analyzing genetic and epigenetic HORMAD alterations in breast cancer resistance and metastatic events.

Published in:

Journal of Research in Pharmacy, 2025, v. 29, n. 1, p. 137, doi. 10.12991/jrespharm.1628559

By:

HERMAWAN, Adam;
PUTRI, Herwandhani

Publication type:

Article

Computational analysis of G-protein-coupled receptor kinase family members as potential targets for colorectal cancer therapy.

Published in:

Egyptian Journal of Medical Human Genetics, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s43042-022-00349-y

By:

Hermawan, Adam;
Putri, Herwandhani

Publication type:

Article

Bioinformatics Analysis of TIMP1, HK2 and IGFBP7 as Potential Biomarkers and Therapeutic Targets of Paclitaxel Resistance in Breast Cancer.

Published in:

Middle East Journal of Cancer, 2021, v. 12, n. 2, p. 198, doi. 10.30476/mejc.2020.83374.1159

By:

Hermawan, Adam;
Putri, Herwandhani

Publication type:

Article

Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance.

Published in:

Molecular Diversity, 2020, v. 24, n. 4, p. 933, doi. 10.1007/s11030-019-10003-2

By:

Hermawan, Adam;
Putri, Herwandhani;
Utomo, Rohmad Yudi

Publication type:

Article

Targets and molecular mechanisms of a citrus flavonoid, hesperidin, against luminal breast cancer cells: an integrative bioinformatics analysis.

Published in:

Asian Pacific Journal of Tropical Biomedicine, 2019, v. 9, n. 12, p. 531, doi. 10.4103/2221-1691.271727

By:

Hermawan, Adam;
Putri, Herwandhani

Publication type:

Article

Cardioprotective and hepatoprotective effects of Citrus hystrix peels extract on rats model

Published in:

Asian Pacific Journal of Tropical Biomedicine, 2013, v. 3, n. 5, p. 371, doi. 10.1016/S2221-1691(13)60079-9

By:

Putri, Herwandhani;
Nagadi, Standie;
Larasati, Yonika Arum;
Wulandari, Nindi;
Hermawan, Adam

Publication type:

Article

Characterizing excision repair cross-complementing family genes as drug resistance biomarkers in breast cancer.

Published in:

Beni-Suef University Journal of Basic & Applied Sciences, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s43088-023-00415-3

By:

Hermawan, Adam;
Putri, Herwandhani

Publication type:

Article

Bioinformatics and In Vitro Studies Reveal the Importance of p53, PPARG and Notch Signaling Pathway in Inhibition of Breast Cancer Stem Cells by Hesperetin.

Published in:

Advanced Pharmaceutical Bulletin, 2021, v. 11, n. 2, p. 351, doi. 10.34172/apb.2021.033

By:

Hermawan, Adam;
Ikawati, Muthi;
Khumaira, Annisa;
Putri, Herwandhani;
Jenie, Riris Istighfari;
Angraini, Sonia Meta;
Muflikhasari, Haruma Anggraini

Publication type:

Article

The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells.

Published in:

Advanced Pharmaceutical Bulletin, 2021, v. 11, n. 1, p. 188

By:

Meiyanto, Edy;
Husnaa, Ulfatul;
Kastian, Ria Fajarwati;
Putri, Herwandhani;
Larasati, Yonika Arum;
Khumaira, Annisa;
Pamungkas, Dyaningtyas Dewi Putri;
Jenie, Riris Istighfari;
Kawaichi, Masashi;
Lestari, Beni;
Yokoyama, Takashi;
Kato, Jun-ya

Publication type:

Article

Anti-proliferative and Anti-metastatic Potential of Curcumin Analogue, Pentagamavunon-1 (PGV-1), Toward Highly Metastatic Breast Cancer Cells in Correlation with ROS Generation.

Published in:

Advanced Pharmaceutical Bulletin, 2019, v. 9, n. 3, p. 445, doi. 10.15171/apb.2019.053

By:

Meiyanto, Edy;
Putri, Herwandhani;
Larasati, Yonika Arum;
Utomo, Rohmad Yudi;
Jenie, Riris Istighfari;
Ikawati, Muthi;
Lestari, Beni;
Noriko Yoneda-Kato;
Ikuko Nakamae;
Masashi Kawaichi;
Jun-Ya Kato

Publication type:

Article

Functional network analysis reveals potential repurposing of β-blocker atenolol for pancreatic cancer therapy.

Published in:

DARU: Journal of Pharmaceutical Sciences, 2020, v. 28, p. 685, doi. 10.1007/s40199-020-00375-4

By:

Hermawan, Adam;
Putri, Herwandhani;
Utomo, Rohmad Yudi

Publication type:

Article

Bioinformatics Analysis of Programmed Death-1–Trastuzumab Resistance Regulatory Networks in Breast Cancer Cells.

Published in:

Asian Pacific Journal of Cancer Prevention, 2025, v. 26, n. 1, p. 279, doi. 10.31557/APJCP.2025.26.1.279

By:

Hermawan, Adam;
Putri, Herwandhani

Publication type:

Article